Trial record 1 of 44 for:
bryostatin
Safety of Bryostatin in Patients With MS
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT06190912 |
|
Recruitment Status :
Recruiting
First Posted : January 5, 2024
Last Update Posted : May 2, 2024
|
Sponsor:
Robert Fox
Collaborator:
Synaptogenix, Inc.
Information provided by (Responsible Party):
Robert Fox, The Cleveland Clinic
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | April 2026 |
| Estimated Study Completion Date : | August 2026 |